Sodium‐glucose co‐transporter ( SGLT )2 and SGLT1 renal expression in patients with type 2 diabetes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sodium‐glucose co‐transporter ( SGLT )2 and SGLT1 renal expression in patients with type 2 diabetes

Published:2017-05-22 Issue:9 Volume:19 Page:1289-1294
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Solini Anna¹^ORCID,Rossi Chiara²,Mazzanti Chiara M.³,Proietti Agnese¹,Koepsell Hermann⁴,Ferrannini Ele⁵^ORCID

Affiliation:

1. Department of Surgical, Medical, Molecular and Critical Area PathologyUniversity of Pisa Pisa Italy

2. Department of Clinical and Experimental MedicineUniversity of Pisa Pisa Italy

3. Fondazione Pisana per la Scienza Pisa Italy

4. Department of Molecular Plant Physiology and Biophysics, Julius‐von‐Sachs‐InstituteUniversity of Wurzburg Wurzburg Germany

5. CNR Institute of Clinical Physiology Pisa Italy

Funder

University of Pisa

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.12970

Reference24 articles.

1. Renal Na+-glucose cotransporters

2. SGLT2 Mediates Glucose Reabsorption in the Early Proximal Tubule

3. SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice

4. Na+-Glucose Transporter-2 Messenger Ribonucleic Acid Expression in Kidney of Diabetic Rats Correlates with Glycemic Levels: Involvement of Hepatocyte Nuclear Factor-1α Expression and Activity

5. Glucose Transporters in Human Renal Proximal Tubular Cells Isolated From the Urine of Patients With Non–Insulin-Dependent Diabetes

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The pivotal role of glucose transporter 1 in diabetic kidney disease;Life Sciences;2024-09

2. Effect of Dapagliflozin on Renal and Hepatic Glucose Kinetics in T2D and NGT Subjects;Diabetes;2024-03-21

3. SGLT2 Inhibitor Canagliflozin Alleviates High Glucose-Induced Inflammatory Toxicity in BV-2 Microglia;Biomedicines;2023-12-22

4. Narrative review investigating the nephroprotective mechanisms of sodium glucose cotransporter type 2 inhibitors in diabetic and nondiabetic patients with chronic kidney disease;Frontiers in Endocrinology;2023-12-20

5. Time to completely eradicate diabetic nephropathy;Diabetic Nephropathy;2023-09-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3